UBS Maintains Neutral on Amrize, Lowers Price Target to $42
UBS analyst Julian Radlinger maintains Amrize (NYSE:AMRZ) with a Neutral and lowers the price target from $57 to $42.
Stocks · News reference
Deutsche Bank Maintains Buy on Amrize, Lowers Price Target to $56
Deutsche Bank analyst Jon Bell maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $64 to $56.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $55
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $62 to $55.
8-K filing — Amrize Ltd (AMRZ)
Filed: 2026-09-11 AccNo: 0001140361-26-036349 Size: 181 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits